Deferred Tax Assets, Valuation Allowance of THC Therapeutics, Inc. from 14 Mar 2012 to 31 Jul 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
THC Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 14 Mar 2012 to 31 Jul 2024.
  • THC Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Jul 2024 was $8,239,456, a 2.1% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

THC Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $8,239,456 +$170,428 +2.1% 31 Jul 2024 10-K 27 Feb 2026 2024 FY
Q2 2023 $8,069,028 +$81,247 +1% 31 Jul 2023 10-K 27 Feb 2026 2024 FY
Q2 2022 $7,987,781 +$319,005 +4.2% 31 Jul 2022 10-K 26 Feb 2024 2023 FY
Q2 2021 $7,668,776 +$395,944 +5.4% 31 Jul 2021 10-K 25 Nov 2022 2022 FY
Q2 2020 $7,272,832 +$8,947,452 31 Jul 2020 10-K 31 Mar 2022 2021 FY
Q2 2019 $1,674,620 +$35,154 +2.1% 31 Jul 2019 10-K/A 18 Nov 2019 2020 FY
Q2 2018 $1,709,774 31 Jul 2018 10-K/A 18 Nov 2019 2020 FY
Q1 2014 $669,256 +$505,981 +310% 30 Apr 2014 10-Q 12 Jun 2014 2013 Q3
Q4 2013 $640,349 +$483,974 +309% 31 Jan 2014 10-Q 12 Jun 2014 2013 Q2
Q3 2013 $591,517 +$452,445 +325% 31 Oct 2013 10-Q 11 Jun 2014 2013 Q1
Q2 2013 $517,497 +$385,263 +291% 31 Jul 2013 10-Q 12 Jun 2014 2013 Q3
Q1 2013 $163,275 -$354,222 -68% 30 Apr 2013 10-Q 11 Jun 2013 2013 Q3
Q4 2012 $156,375 31 Jan 2013 10-Q 21 Mar 2013 2013 Q2
Q3 2012 $139,072 31 Oct 2012 10-Q 14 Dec 2012 2013 Q1
Q2 2012 $132,234 31 Jul 2012 10-K 09 Jun 2014 2013 FY
Q1 2012 $517,497 14 Mar 2012 10-Q 11 Jun 2014 2013 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.